GPT and metabolic dysfunction-associated steatotic liver disease: Key interrelated indicators, including ALT, MetS, gut microbiota, oxidative stress, and adipose tissue inflammation, strongly associated with both MASLD/NAFLD and CVD, should be integrated into cardiovascular risk screening protocols.